104 related articles for article (PubMed ID: 22402431)
1. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
Peker D; Martinez AE; Schwartz MA; Cusnir M
Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
[No Abstract] [Full Text] [Related]
2. HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
Boulanger E; Brière J; Gaulard P; Droz D; Oksenhendler E
Am J Hematol; 2003 Jan; 72(1):70-1. PubMed ID: 12508272
[No Abstract] [Full Text] [Related]
3. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
4. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
5. Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.
Patier de la Peña JL; González-García A; Prieto Pareja E; Norman FF; Rojas Marcos J; Benito Paniagua D
Rev Clin Esp (Barc); 2014 Mar; 214(2):e15-7. PubMed ID: 24365755
[No Abstract] [Full Text] [Related]
6. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
[TBL] [Abstract][Full Text] [Related]
7. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
[TBL] [Abstract][Full Text] [Related]
9. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
[No Abstract] [Full Text] [Related]
10. Unicentric Castleman disease relapsed after rituximab-CHOP chemotherapy or radiation therapy in an adolescent.
Baek HJ; Kook H; Han DK; Shin MG; Kim HS; Hwang TJ
J Pediatr Hematol Oncol; 2012 Jul; 34(5):e206-8. PubMed ID: 22258344
[TBL] [Abstract][Full Text] [Related]
11. Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient.
Osa M; Maeda T; Misawa K; Imai K; Fujikura Y; Kawana A
J Infect Chemother; 2016 Dec; 22(12):804-807. PubMed ID: 27373909
[TBL] [Abstract][Full Text] [Related]
12. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
[No Abstract] [Full Text] [Related]
13. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
[TBL] [Abstract][Full Text] [Related]
14. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
[TBL] [Abstract][Full Text] [Related]
15. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric Castleman disease.
Tajima K; Yamamoto H; Suzuki I; Kato Y; Hatano K; Takahashi S; Sato M; Kato T
Ann Hematol; 2013 Jun; 92(6):849-51. PubMed ID: 23180435
[No Abstract] [Full Text] [Related]
17. Multicentric Castleman disease, Kaposi sarcoma, hemophagocytic syndrome, and a novel HHV8-lymphoproliferative disorder.
Yates JA; Zakai NA; Griffith RC; Wing EJ; Schiffman FJ
AIDS Read; 2007 Dec; 17(12):596-8, 601. PubMed ID: 18178978
[TBL] [Abstract][Full Text] [Related]
18. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
[TBL] [Abstract][Full Text] [Related]
20. Mixed variant multicentric Castleman disease treated with rituximab: case report.
Mian H; Leber B
J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
